Recap: Cidara Therapeutics Q2 Earnings



Cidara Therapeutics CDTX reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Cidara Therapeutics beat estimated earnings by 32.14%, reporting an EPS of $-0.19 versus an estimate of $-0.28.

Revenue was down $26.65 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 22.66% drop in the share price the next day.

Here's a look at Cidara Therapeutics's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.29 -0.34 -0.36 -0.08
EPS Actual -0.27 -0.26 -0.37 0.18
Revenue Estimate 6.11M 4.31M 2.94M 18.20M
Revenue Actual 7.11M 7.22M 7.08M 32.86M

To track all earnings releases for Cidara Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps